Manitoba

Manitoba’s vibrant life sciences ecosystem has emerged as a premier Canadian hub for biomanufacturing and biotechnology, strategically positioned as the leading pharmaceutical manufacturing center in Western Canada.

The province is internationally recognized for its expertise in vaccine development and infectious disease research, anchored by the National Microbiology Laboratory, which serves as Canada’s only Level 4 biocontainment facility.

As the second-largest pharmaceutical manufacturing hub in the country, Manitoba hosts global industry leaders such as Bausch Health and Pfizer, contributing to a sector that generates over $10 billion in annual revenue.

The medtech and medical device sectors continue to scale through innovations in digital health and diagnostic tools, supported by robust resources like the Manitoba Technology Accelerator.

Complementing this industrial strength, the University of Manitoba and the Children’s Hospital Research Institute of Manitoba drive world-class clinical trials and healthcare innovation with a focus on precision medicine and health equity.

A unique strength of the region is its ag-biotech synergy, where deep roots in agriculture fuel advancements in plant science and animal health through a holistic "One Health" approach.

This dynamic environment fosters seamless collaboration between healthcare innovation networks and private industry, ensuring that breakthrough discoveries move rapidly from the lab to the global marketplace.

With a skilled workforce of more than 14,000 professionals, Manitoba offers a highly competitive, low-cost environment for R&D investment and global commercialization.

Whether through cutting-edge proteomics or advanced medical engineering, the province provides the essential infrastructure and top-tier talent required to lead the next generation of global life sciences advancements.